Analytical Data
-
Gene name
OsI
- Application
-
Alternative Names
OsI；APETALA2-like Protein 5
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q13501
-
Expression Region
1-35aa
-
AA Sequence
MAMSYVKDDIFRIYIKEKKECRRDHRPPCAQEAPRNMVHPNVICDGCNGPVVGTRYKCSV CPDYDLCSVCEGKGLHRGHTKLAFPSPFGHLSEGFSHSRWLRKVKHGHFGWPGWEMGPPG NWSPRPPRAGEARPGPTAESASGPSEDPSVNFLKNVGESVAAALSPLGIEVDIDVEHGGK RSRLTPVSPESSSTEEKSSSQPSSCCSDPSKPGGNVEGATQSLAEQMRKIALESEGRPEE QMESDNCSGGDDDWTHLSSKEVDPSTGELQSLQMPESEGPSSLDPSQEGPTGLKEAALYP HLPPEADPRLIESLSQMLSMGFSDEGGWLTRLLQTKNYDIGAALDTIQYSKHPPPL
-
Molecular Weight
47.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The OSI (Oncogenic Signal Induction) recombinant proteins have garnered significant attention in the field of cancer research due to their potential role in the modulation of signaling pathways that contribute to tumorigenesis. These proteins are often derived from oncogenes, which are genes that have the potential to cause cancer when mutated or expressed at high levels. Studies have shown that aberrant activation of OSI proteins can lead to uncontrolled cell proliferation, evasion of apoptosis, and metastasis, making them pivotal in understanding the mechanisms of cancer development. Recombinant technology allows researchers to produce these proteins in controlled environments, facilitating the study of their biochemical properties and interactions. This research background underscores the importance of OSI recombinant proteins not only in elucidating the molecular underpinnings of cancer but also in the development of targeted therapies. By manipulating these proteins, scientists aim to uncover novel therapeutic strategies and improve treatment outcomes for cancer patients, emphasizing their relevance in modern oncology.
